FindTrial
Sign In

Study on the correlation between cognitive function and HDAC2 expression and its gene polymorphism in patients with schizophrenia

Study on the correlation between cognitive function and HDAC2 expression and its gene polymorphism in patients with schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039484
Enrollment
Unknown
Registered
2020-10-29
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

schizophrenia group:Nil
health control group:Nil

Sponsors

The First Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 56 Years

Inclusion criteria

Inclusion criteria: 1. In line with the International Classification of Diseases (Tenth Edition) (ICD-10) diagnostic criteria for schizophrenia, and refer to the Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5). 2. Informed consent, voluntary participation.

Exclusion criteria

Exclusion criteria: 1. Cognitive disorders secondary to other mental or physical diseases; 2. Organic mental disorders, including mental retardation; severe physical diseases; 3. Persons who abused alcohol or drugs within the year before screening; 3. Breastfeeding, pregnancy or women of childbearing age who not taking reasonable contraception; 4. Involuntary patients or who drop out in the process.

Design outcomes

Primary

MeasureTime frame
Histone deacetylase2;—

Countries

China

Contacts

Public ContactRan Wang

The First Hospital of Hebei Medical University

wangran104@hotmail.com+86 15633834532

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026